Cargando…
Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma
Juvenile xanthogranuloma (JXG) is a rare histiocytic disorder that is usually benign and self-limiting. We present a case of atypical, aggressive JXG harboring a novel mitogen-activated protein kinase (MAPK) pathway mutation in the MAPK1 gene, which encodes mitogen-activated protein kinase 1 or extr...
Autores principales: | Chakraborty, Rikhia, Hampton, Oliver A., Abhyankar, Harshal, Zinn, Daniel J., Grimes, Amanda, Skull, Brooks, Eckstein, Olive, Mahmood, Nadia, Wheeler, David A., Lopez-Terrada, Dolores, Peters, Tricia L., Hicks, John M., Elghetany, Tarek, Krance, Robert, Poulikakos, Poulikos I., Merad, Miriam, McClain, Kenneth L., Allen, Carl E., Parsons, Donald W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542249/ https://www.ncbi.nlm.nih.gov/pubmed/28512266 http://dx.doi.org/10.18632/oncotarget.17521 |
Ejemplares similares
-
Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis
por: Zinn, Daniel J, et al.
Publicado: (2019) -
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
por: Berres, Marie-Luise, et al.
Publicado: (2014) -
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
por: Berres, Marie-Luise, et al.
Publicado: (2015) -
Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF(V600E)
por: Milne, Paul, et al.
Publicado: (2022) -
Necrobiotic Xanthogranuloma
por: Girisha, Banavasi S, et al.
Publicado: (2012)